Hansa Biopharma AB
Biotechnology · Healthcare
CFO
1 appearance
Latest appearance 2026-07-22
CFO
Hansa Biopharma AB
Equibles does not estimate personal net worth.
Adam Cutler is recorded as CFO at Hansa Biopharma AB. Adam Cutler has spoken on 1 earnings call across 1 company, most recently for Hansa Biopharma AB on July 22, 2026. Hansa Biopharma AB is classified in the Biotechnology industry within the Healthcare sector.
“Total revenue for Q2 2026 was 48.1 million Swedish krona, representing a 2% decrease compared to Q2 2025 of 49.1 million Swedish krona. Product sales for Q2 2026 were 46.8 million Swedish krona, representing a 2% decrease as compared to Q2 2025 of 47.8 million Swedish krona.”
Hansa Biopharma AB
CFO
Transcript header (unverified)
Hansa Biopharma AB
Biotechnology · Healthcare
CFO
Interim Report January-June 2026 Conference Call
Hansa Biopharma AB